PL3209673T5 - Mieszaniny hmo - Google Patents

Mieszaniny hmo

Info

Publication number: PL3209673T5
Authority: PL; Poland
Prior art keywords: hmos; mixtures
Prior art date: 2014-10-24

Application number

PL15852675.6T

Other languages

English (en)

Other versions

PL3209673T3 (pl

Inventor

Elise Champion

Bruce Mcconnell

Gyula Dekany

Original Assignee

Glycom A/S

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2014-10-24

Filing date

2015-10-23

Publication date

2023-10-23

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55760374&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3209673(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2015-10-23 Application filed by Glycom A/S filed Critical Glycom A/S

2021-01-25 Publication of PL3209673T3 publication Critical patent/PL3209673T3/pl

2023-10-23 Publication of PL3209673T5 publication Critical patent/PL3209673T5/pl

Links

238000004977 Hueckel calculation Methods 0.000 title 1
239000000203 mixture Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
- C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
- C07H5/06—Aminosugars
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/18—Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y204/00—Glycosyltransferases (2.4)
- C12Y204/01—Hexosyltransferases (2.4.1)
- C12Y204/01065—3-Galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase (2.4.1.65), i.e. alpha-1-3 fucosyltransferase

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Molecular Biology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
Epidemiology (AREA)
Microbiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Immunology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)

PL15852675.6T 2014-10-24 2015-10-23 Mieszaniny hmo PL3209673T5 (pl)

Applications Claiming Priority (10)

Application Number	Priority Date	Filing Date	Title
EP14190374		2014-10-24
EP15155460		2015-02-17
EP15155457		2015-02-17
EP15155450		2015-02-17
EP15155454		2015-02-17
EP15163044		2015-04-09
EP15163047		2015-04-09
EP15163045		2015-04-09
PCT/IB2015/058198 WO2016063262A1 (en)	2014-10-24	2015-10-23	MIXTURES OF HMOs
EP15852675.6A EP3209673B2 (en)	2014-10-24	2015-10-23	Mixtures of human milk oligosaccharides

Publications (2)

Publication Number	Publication Date
PL3209673T3 PL3209673T3 (pl)	2021-01-25
PL3209673T5 true PL3209673T5 (pl)	2023-10-23

Family

ID=55760374

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL15852675.6T PL3209673T5 (pl)	2014-10-24	2015-10-23	Mieszaniny hmo

Country Status (7)

Country	Link
US (2)	US10314852B2 (pl)
EP (1)	EP3209673B2 (pl)
CN (1)	CN107108677B (pl)
DK (1)	DK3209673T4 (pl)
ES (1)	ES2824679T5 (pl)
PL (1)	PL3209673T5 (pl)
WO (1)	WO2016063262A1 (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL3209673T5 (pl) *	2014-10-24	2023-10-23	Glycom A/S	Mieszaniny hmo
WO2021111422A1 (en) *	2019-12-06	2021-06-10	Glycom A/S	Composition comprising 2'-fl and dfl for use in a method for reducing pain
US11179405B2 (en) *	2016-09-07	2021-11-23	Societe Des Produits Nestle S.A.	Nutritional compositions for infants and/or young children comprising oligosaccharides
WO2018215961A1 (en) *	2017-05-24	2018-11-29	Glycom A/S	Synthetic composition comprising oligosaccharides and its use in medical treatment.
WO2019003135A1 (en)	2017-06-30	2019-01-03	Glycom A/S	PURIFICATION OF OLIGOSACCHARIDES
KR102741265B1 (ko) *	2017-11-30	2024-12-11	글리콤 에이/에스	미생물총 조절을 위한 인간 밀크 올리고당 및 그의 합성 조성물
EP4093876A1 (en) *	2020-01-23	2022-11-30	Glycom A/S	New major facilitator superfamily (mfs) protein (fred) in hmo production
CA3188909A1 (en) *	2020-08-10	2022-02-17	Sofie AESAERT	Production of an oligosaccharide mixture by a cell
EP4392014A1 (en) *	2021-08-24	2024-07-03	DSM IP Assets B.V.	Novel use of at least a human milk oligosaccharide
EP4418878A1 (en)	2021-10-18	2024-08-28	DSM IP Assets B.V.	A method for providing an amorphous hmo product by drying
DK202200588A1 (en) *	2022-06-20	2024-02-23	Dsm Ip Assets Bv	Mixture of fucosylated HMOs
DK181911B1 (en) *	2022-07-15	2025-03-18	Dsm Ip Assets Bv	GENETICALLY ENGINEERED CELLS COMPRISING A RECOMBINANT NUCLEIC ACID SEQUNCE ENCODING A FUCOSYLTRANSFERASE FOR IN VIVO SYNTHESIS OF COMPLEX FUCOSYLATED HUMAN MILK OLIGOSACCHARIDES (HMOs) AND METHODS FOR PRODUCING THE HMOs AND USE OF THE ENZYME
EP4577061A1 (en)	2022-08-25	2025-07-02	DSM IP Assets B.V.	Hybrid method for producing complex hmos
CN120265786A (zh)	2022-11-25	2025-07-04	帝斯曼知识产权资产管理有限公司	用于生产寡糖的双菌株系统

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0686684A (ja)	1992-05-26	1994-03-29	Monsanto Co	シアロ抱合体の合成
DE19701382A1 (de) *	1997-01-16	1998-07-23	Nutricia Nv	Kohlenhydratmischung
US6045854A (en)	1997-03-31	2000-04-04	Abbott Laboraties	Nutritional formulations containing oligosaccharides
FR2796082B1 (fr)	1999-07-07	2003-06-27	Centre Nat Rech Scient	Procede de production d'oligosaccharides
WO2005055944A2 (en)	2003-12-05	2005-06-23	Cincinnati Children's Hospital Medical Center	Oligosaccharide compositions and use thereof in the treatment of infection
WO2007101862A1 (en)	2006-03-09	2007-09-13	Centre National De La Recherche Scientifique (Cnrs)	Method of producing sialylated oligosaccharides
EP2069520A4 (en)	2006-09-15	2010-05-05	Univ California	GENESQUES FROM BIFIDOBACTERIA AND THEIR USE
EP2405524B1 (en)	2009-03-05	2015-10-07	Nissan Motor Co., Ltd.	Bipolar secondary cell and method for producing the same
CN102459294A (zh)	2009-04-07	2012-05-16	格礼卡姆股份公司	2’-o-岩藻糖基乳糖的合成
WO2011100979A1 (en)	2010-02-19	2011-08-25	Glycom A/S	Production of 6'-o-sialyllactose and intermediates
EP3241836B1 (en)	2010-02-19	2024-10-30	Glycom A/S	Polymorph of a tetrasaccharide containing nacetyl-lactosamine
MY191538A (en)	2010-12-31	2022-06-30	Abbott Lab	Human milk oligosaccharides to promote growth of beneficial bacteria
DE12746649T1 (de) *	2011-02-16	2016-09-29	Glycosyn LLC	Biosynthese menschlicher milcholigosaccaride in manipulierten Bakterien
WO2012158517A1 (en)	2011-05-13	2012-11-22	Glycosyn LLC	The use of purified 2'-fucosyllactose, 3-fucosyllactose and lactodifucotetraose as prebiotics
CN103562401A (zh) *	2011-05-13	2014-02-05	格力康公司	产生人乳寡糖(hmo)或其前体的方法
WO2012155916A1 (en)	2011-05-13	2012-11-22	Glycom A/S	Manufacture of lacto-n-tetraose
JP5834484B2 (ja) *	2011-05-13	2015-12-24	味の素株式会社	フコシル化されたＧａｌ−Ｇｌｃまたはその誘導体の製造方法
CN103562214B9 (zh)	2011-05-13	2016-12-14	格力康公司	人乳寡糖(hmo)或其前体的多样化
EP2522232A1 (en)	2011-05-13	2012-11-14	Nestec S.A.	Nutritional products comprising human milk oligosaccharides and methods for manufacture thereof
NL2007268C2 (en) *	2011-08-16	2013-02-19	Friesland Brands Bv	Nutritional compositions comprising human milk oligosaccharides and uses thereof.
EP2760875A4 (en)	2011-09-30	2015-08-26	Glycom As	SYNTHESIS OF HMO NUCLEAR STRUCTURES
WO2013091660A1 (en)	2011-12-23	2013-06-27	Glycom A/S	A method for obtaining crystalline lacto-n-tetraose and lacto-n-neotetraose precursors and mixtures thereof
WO2013139344A1 (en)	2012-03-20	2013-09-26	Glycom A/S	Synthesis of the trisaccharide 3-o-fucosyllactose and intermediates thereof
CN104507483A (zh)	2012-04-13	2015-04-08	波士顿学院理事会	益生元组合物及使用方法
EP2656862A1 (en)	2012-04-24	2013-10-30	The Procter & Gamble Company	Substrate comprising one or more human milk oligosaccharides and disposable absorbent article comprising the substrate
DE202013012829U1 (de) *	2012-06-14	2020-03-04	Glycom A/S	Verbesserung der Stabilität und Reinheit sowie Erhöhung der Bioverfügbarkeit von menschlichen Milch-Oligosacchariden oder Vorläufern oder Mischungen davon
WO2013190530A1 (en)	2012-06-22	2013-12-27	Glycom A/S	Modified galactooligosaccharides
WO2014090261A1 (en)	2012-12-14	2014-06-19	Glycom A/S	Mixture of fucosylate lactoses
EP2857410A1 (en)	2013-10-04	2015-04-08	Jennewein Biotechnologie GmbH	Process for purification of 2´-fucosyllactose using simulated moving bed chromatography
CN105722409A (zh) *	2013-11-15	2016-06-29	雀巢产品技术援助有限公司	用于预防或治疗婴儿和幼儿的坏死性小肠结肠炎的组合物
PL3209673T5 (pl) *	2014-10-24	2023-10-23	Glycom A/S	Mieszaniny hmo
EP3212197A4 (en) *	2014-10-29	2018-07-11	Glycom A/S	Synthetic composition and method for treating irritable bowel syndrome

2015
- 2015-10-23 PL PL15852675.6T patent/PL3209673T5/pl unknown
- 2015-10-23 CN CN201580057758.1A patent/CN107108677B/zh active Active
- 2015-10-23 DK DK15852675.6T patent/DK3209673T4/da active
- 2015-10-23 WO PCT/IB2015/058198 patent/WO2016063262A1/en not_active Ceased
- 2015-10-23 US US15/521,582 patent/US10314852B2/en active Active
- 2015-10-23 EP EP15852675.6A patent/EP3209673B2/en active Active
- 2015-10-23 ES ES15852675T patent/ES2824679T5/es active Active
2019
- 2019-06-10 US US16/435,949 patent/US10946032B2/en active Active

Also Published As

Publication number	Publication date
ES2824679T5 (es)	2023-12-11
PL3209673T3 (pl)	2021-01-25
EP3209673A4 (en)	2018-06-13
US20170312298A1 (en)	2017-11-02
US10946032B2 (en)	2021-03-16
US10314852B2 (en)	2019-06-11
CN107108677B (zh)	2020-08-07
EP3209673A1 (en)	2017-08-30
WO2016063262A1 (en)	2016-04-28
EP3209673B2 (en)	2023-07-26
ES2824679T3 (es)	2021-05-13
CN107108677A (zh)	2017-08-29
DK3209673T4 (da)	2023-10-02
DK3209673T3 (en)	2020-11-02
EP3209673B1 (en)	2020-08-19
US20190290667A1 (en)	2019-09-26

Publication	Publication Date	Title
ZA201804691B (en)	2020-07-29	Mixture of hmos
SG11201609265RA (en)	2016-12-29	Characterizing states of subject
AP2017009836A0 (en)	2017-03-31	Aminopyridyloxypyrazole compounds
GB201419865D0 (en)	2014-12-24	Solution
DK3209673T3 (en)	2020-11-02	Mixtures of HMOs
GB201411418D0 (en)	2014-08-13	Compounds
GB201410430D0 (en)	2014-07-23	Compounds
GB201402431D0 (en)	2014-03-26	Compounds
GB201415569D0 (en)	2014-10-15	Therapeutic Compounds
SI3524234T1 (sl)	2021-05-31	Trdne oblike sofosbuvira
SG11201601030VA (en)	2016-08-30	Massager
GB201406591D0 (en)	2014-05-28	Compounds
GB201406956D0 (en)	2014-06-04	Compounds
GB201404987D0 (en)	2014-05-07	Compounds
GB201412660D0 (en)	2014-08-27	Compounds
IL246979A0 (en)	2016-09-29	Crystalline forms of sofosbuvir
AP2017009778A0 (en)	2017-03-31	Azetidinyloxyphenylpyrrolidine compounds
GB201416788D0 (en)	2014-11-05	Therapeutic applications for pyocins
GB201416273D0 (en)	2014-10-29	Therapeutic compounds
GB201419650D0 (en)	2014-12-17	Modified heterocyclase
GB2544217B (en)	2020-03-25	Chlorination of sucrose-6-esters
GB201407695D0 (en)	2014-06-18	Compounds
GB201405361D0 (en)	2014-05-07	Compounds
IL249332A0 (en)	2017-02-28	Crystalline forms of sofosbuvir
TWM490229U (en)	2014-11-21	Improved structure of glove